ArticleCancer medicine2024

The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.

Jia-Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.